Journal of Neurology and Neurorehabilitation Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Rapid Communication - Journal of Neurology and Neurorehabilitation Research (2024) Volume 9, Issue 6

Innovations in Treating Neurological Disorders in Children: A Comprehensive Approach

Colleen Nitsche *

College of Medicine, University of Lagos, Nigeria

*Corresponding Author:
Colleen Nitsche
College of Medicine, University of Lagos, Nigeria
E-mail: colleen@lu.ng.co.in

Received: 25-Oct-2024, Manuscript No. JNNR-24-155326; Editor assigned: 26-Oct-2024, PreQC No. JNNR-24-155326(PQ); Reviewed: 09-Nov-2024, QC No. JNNR-24-155326; Revised: 15-Nov-2024, Manuscript No. JNNR-24-155326(R); Published: 22-Nov-2024, DOI: 10.35841/aajnnr-9.6.239

Citation: : Nitsche C. Innovations in treating neurological disorders in children: A comprehensive approach. J Neurol Neurorehab Res.2024;9(6):239

Introduction

Innovations in treating neurological disorders in children have transformed the landscape of pediatric care, offering new hope for young patients and their families [1]. A comprehensive approach that integrates advances in technology, genetics, pharmacology, and rehabilitation therapies is enabling more effective management and treatment of conditions such as epilepsy, cerebral palsy, and neurodevelopmental disorders [2].

One key innovation is the use of precision medicine, which tailors treatment plans based on a child’s unique genetic profile. Advances in genetic testing have identified mutations associated with specific neurological disorders, such as Rett syndrome and spinal muscular atrophy (SMA) [3]. Gene-targeted therapies, like nusinersen for SMA, address the root causes of these conditions rather than merely alleviating symptoms. Such targeted treatments have improved outcomes significantly, altering the natural progression of these disorders [4].

Technological advancements, particularly in neuroimaging, have enhanced diagnostic accuracy. Functional MRI and magnetoencephalography (MEG) allow clinicians to map brain activity and pinpoint the areas responsible for seizures or other dysfunctions [5]. This has improved the success rates of surgical interventions, such as epilepsy surgery, which can dramatically reduce or even eliminate seizures in some children [6].

Non-invasive brain stimulation techniques, like transcranial magnetic stimulation (TMS), are being explored for their potential in treating conditions like depression and movement disorders in children. These methods are less invasive than traditional surgical approaches and offer a promising alternative for certain patients [7].

Rehabilitation therapies have also seen significant advancements. Neuroplasticity-based approaches, such as constraint-induced movement therapy and robot-assisted rehabilitation, leverage the brain’s ability to reorganize itself to recover lost functions [8]. Coupled with early intervention programs, these therapies are helping children achieve milestones previously thought unattainable [9].

Pharmacological innovations, including newer anticonvulsants and medications targeting specific neurotransmitter imbalances, have improved symptom control for many pediatric neurological disorders. These treatments minimize side effects while optimizing efficacy [10].

Conclusion

This holistic and innovative approach to treating neurological disorders in children not only improves their quality of life but also fosters independence and long-term well-being, marking a significant leap forward in pediatric neurology.

References

  1. Arora R, Baldi A. Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies. Curr Pharm Des. 2024;30(19):1459-71.

    2. Indexed at, Google Scholar, Cross Ref

  2. Buccilli B. Exploring new horizons: Emerging therapeutic strategies for pediatric stroke. Exp Neurol. 2024:114701.

    3. Indexed at, Google Scholar, Cross Ref

  3. Perrin JM, Anderson LE, Van Cleave J. The rise in chronic conditions among infants, children, and youth can be met with continued health system innovations. Health Aff (Millwood). 2014;33(12):2099-105.

    4. Indexed at, Google Scholar, Cross Ref

  4. Keller MB, Lavori PW, Friedman B, et al. The longitudinal interval follow-up evaluation: A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540-8.

    5. Indexed at, Google Scholar, Cross Ref

  5. Wei Y, Qiao Z. Neurologic Music Therapy's Impact on Neurological Disorders. J Neurosci Res. 2024;102(12):70000.

    6. Indexed at, Google Scholar, Cross Ref

  6. Wakabayashi H, Sakuma K. Comprehensive Approach to Sarcopenia and Cachexia Treatment. PSM: Mechanisms to Applications. 2017:155-78.

    7. Google Scholar

  7. Begley D, Gabathuler R, Pastores G, et al. Challenges and opportunities in neurometabolic disease treatment with enzyme delivery. Expert Opin Drug Deliv. 2024;21(6):817-28.

    8. Indexed at, Google Scholar, Cross Ref

  8. Whitehouse P. The challenges of cognitive aging: Integrating approaches from neuroscience to intergenerational relationships. J Alzheimers Dis. 2013;11(2):105-17.

    9. Indexed at, Google Scholar, Cross Ref

  9. Komalasari R. Unravelling the Veil: Exploring the Nexus of Insecure Attachment and Functional Somatic Disorders in Adults. IDHTICS. 2024:1-27.

    10. Google Scholar

  10. Mateen FJ. Progress towards the 2030 sustainable development goals: direct and indirect impacts on neurological disorders. J Neurol. 2022;269(9):4623-34.

    11. Indexed at, Google Scholar, Cross Ref

Get the App